What's Happening?
KORU Medical Systems, a company specializing in subcutaneous infusion solutions, has appointed Eric Schiller as its new Chief Technology Officer. Schiller brings over 25 years of experience in device engineering and product development, having previously served as Global Head of Device Development Portfolio at Sanofi. In his new role, Schiller will lead KORU's product development and innovation pipeline, focusing on integrating portfolio planning with the evolving needs of the company's global customer base. His appointment is part of KORU's strategy to expand its technology and platform capabilities, enhancing patient-centric solutions.
Why It's Important?
The appointment of Eric Schiller as CTO is a strategic move for KORU Medical Systems as it seeks to strengthen
its position in the medical technology industry. Schiller's expertise in device development and product lifecycle management is expected to drive innovation and support the company's growth objectives. By aligning product innovation with market needs, KORU aims to enhance its competitive edge and improve patient outcomes. Schiller's leadership will be crucial in advancing KORU's next-generation platforms and expanding its R&D capabilities, ultimately contributing to the company's long-term success and market expansion.
What's Next?
Under Schiller's leadership, KORU Medical Systems is likely to focus on accelerating its research and development efforts, particularly in the area of subcutaneous drug delivery. The company may explore new therapeutic applications and partnerships to enhance its product offerings. Additionally, KORU is expected to continue its efforts to expand its market presence and strengthen its competitive position. Schiller's strategic mindset and experience in senior technology leadership will be instrumental in guiding KORU through its next phase of growth, ensuring the company remains at the forefront of innovation in the medical technology sector.
